BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 22833947)

  • 21. High-speed photography during ultrasound illustrates potential therapeutic applications of microbubbles.
    Postema M; van Wamel A; ten Cate FJ; de Jong N
    Med Phys; 2005 Dec; 32(12):3707-11. PubMed ID: 16475770
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effective gene delivery with novel liposomal bubbles and ultrasonic destruction technology.
    Suzuki R; Takizawa T; Negishi Y; Utoguchi N; Maruyama K
    Int J Pharm; 2008 Apr; 354(1-2):49-55. PubMed ID: 18082343
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ultrasound contrast agents: basic principles.
    Calliada F; Campani R; Bottinelli O; Bozzini A; Sommaruga MG
    Eur J Radiol; 1998 May; 27 Suppl 2():S157-60. PubMed ID: 9652516
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ultrasound contrast microbubbles in imaging and therapy: physical principles and engineering.
    Qin S; Caskey CF; Ferrara KW
    Phys Med Biol; 2009 Mar; 54(6):R27-57. PubMed ID: 19229096
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Microbubbles as ultrasound contrast agents and in targeted drug delivery.
    Sheffield P; Trehan A; Boyd B; Wong OL
    Crit Rev Biomed Eng; 2008; 36(4):225-55. PubMed ID: 19961426
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acoustic scattering from a contrast agent microbubble near an elastic wall of finite thickness.
    Doinikov AA; Aired L; Bouakaz A
    Phys Med Biol; 2011 Nov; 56(21):6951-67. PubMed ID: 22008736
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-speed optical observations of contrast agent destruction.
    Bouakaz A; Versluis M; de Jong N
    Ultrasound Med Biol; 2005 Mar; 31(3):391-9. PubMed ID: 15749563
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeted ultrasound contrast agent for molecular imaging of inflammation in high-shear flow.
    Klibanov AL; Rychak JJ; Yang WC; Alikhani S; Li B; Acton S; Lindner JR; Ley K; Kaul S
    Contrast Media Mol Imaging; 2006; 1(6):259-66. PubMed ID: 17191766
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bubble dynamics involved in ultrasonic imaging.
    Postema M; Schmitz G
    Expert Rev Mol Diagn; 2006 May; 6(3):493-502. PubMed ID: 16706749
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cavitation microstreaming and stress fields created by microbubbles.
    Collis J; Manasseh R; Liovic P; Tho P; Ooi A; Petkovic-Duran K; Zhu Y
    Ultrasonics; 2010 Feb; 50(2):273-9. PubMed ID: 19896683
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microbubble-mediated ultrasound drug-delivery and therapeutic monitoring.
    Sennoga CA; Kanbar E; Auboire L; Dujardin PA; Fouan D; Escoffre JM; Bouakaz A
    Expert Opin Drug Deliv; 2017 Sep; 14(9):1031-1043. PubMed ID: 27892760
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nonlinear shell behavior of phospholipid-coated microbubbles.
    Overvelde M; Garbin V; Sijl J; Dollet B; de Jong N; Lohse D; Versluis M
    Ultrasound Med Biol; 2010 Dec; 36(12):2080-92. PubMed ID: 21030140
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Imaging with ultrasound contrast agents: current status and future.
    Chong WK; Papadopoulou V; Dayton PA
    Abdom Radiol (NY); 2018 Apr; 43(4):762-772. PubMed ID: 29508011
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Injectable microbubbles as contrast agents for diagnostic ultrasound imaging: the key role of perfluorochemicals.
    Schutt EG; Klein DH; Mattrey RM; Riess JG
    Angew Chem Int Ed Engl; 2003 Jul; 42(28):3218-35. PubMed ID: 12876730
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug and Gene Delivery using Sonoporation for Cardiovascular Disease.
    Castle J; Feinstein SB
    Adv Exp Med Biol; 2016; 880():331-8. PubMed ID: 26486346
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modeling non-spherical oscillations and stability of acoustically driven shelled microbubbles.
    Loughran J; Eckersley RJ; Tang MX
    J Acoust Soc Am; 2012 Jun; 131(6):4349-57. PubMed ID: 22712909
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bleomycin delivery into cancer cells in vitro with ultrasound and SonoVue® or BR14® microbubbles.
    Lamanauskas N; Novell A; Escoffre JM; Venslauskas M; Satkauskas S; Bouakaz A
    J Drug Target; 2013 May; 21(4):407-14. PubMed ID: 23336182
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of ultrasound on adherent microbubble contrast agents.
    Loughran J; Sennoga C; J Eckersley R; Tang MX
    Phys Med Biol; 2012 Nov; 57(21):6999-7014. PubMed ID: 23044731
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Microbubbles and ultrasound: from diagnosis to therapy.
    Dijkmans PA; Juffermans LJ; Musters RJ; van Wamel A; ten Cate FJ; van Gilst W; Visser CA; de Jong N; Kamp O
    Eur J Echocardiogr; 2004 Aug; 5(4):245-56. PubMed ID: 15219539
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of Definity™ ultrasound contrast agent at frequency range of 5-15 MHz.
    Faez T; Goertz D; De Jong N
    Ultrasound Med Biol; 2011 Feb; 37(2):338-42. PubMed ID: 21257093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.